Near‐Infrared Light‐Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image‐Guided Synergistic Phototherapy
Advanced Healthcare Materials · 2024-07 · 13 (19)
DOI: 10.1002/adhm.202400201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 31.03.2024. Verfasst von Xilin Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Organic Solar Cells and Photochemical Conversion, College of Chemistry and Chemical Engineering, Tianjin University of Tech…. Hauptthemen laut MEDLINE: Infrared Rays. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin, Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Photothermal agents (PTAs) with desirable near‐infrared (NIR) absorption and excellent photothermal conversion efficiency (PCE) are ideal candidates for cancer treatment. However, numerous PTAs still require high‐intensity and long‐duration laser irradiation to completely ablate the tumor during the photothermal therapy (PTT) process, resulting in light damage to healthy skin and tissue as well as limiting their biomedical applications. Integrating intense NIR absorption and high PCE into a single small‐molecule PTA is an important prerequisite for realizing efficient PTT, but is a serious challenge. Herein, a series of donor–acceptor type PTAs (CC1 to NC4) are designed through a molecular engineering strategy. Theoretical calculations and experimental results show that the NIR absorption and photothermal effect from CC1 to NC4 are significantly enhanced as expected. Notably, NC4 nanoparticles exhibit intense NIR absorption, superhigh PCE of up to 88.9% for PTT, photoacoustic imaging and photothermal imaging, and effective reactive oxygen species generation for photodynamic therapy (PDT). The superior PTT/PDT synergistic phototherapeutic efficacy is well demonstrated by the complete elimination of tumor in vivo upon one‐time, low‐intensity, and short‐duration laser irradiation (808 nm, 330 mW cm −2 , and 3 min). This work provides a valuable guideline for rational design of PTAs for cancer phototherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Organic Solar Cells and Photochemical Conversion, College of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, 300384, China.
ORCID-Profile: Xiaowei Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Zhao, X., Sun, M., Cao, X., Xu, J., Li, X., Zhao, X., & Lu, H. (2024). Near‐Infrared Light‐Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image‐Guided Synergistic Phototherapy. Advanced Healthcare Materials, 13(19). https://doi.org/10.1002/adhm.202400201
Vancouver
Zhao X, Sun M, Cao X, Xu J, Li X, Zhao X, et al. Near‐Infrared Light‐Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image‐Guided Synergistic Phototherapy. Advanced Healthcare Materials. 2024;13(19). doi:10.1002/adhm.202400201
BibTeX
@article{Zhao2024,
author = {Zhao, Xilin and Sun, Mengxin and Cao, Xiaohan and Xu, Jiashuai and Li, Xiaoyu and Zhao, Xiaowei and Lu, Hongguang},
title = {Near‐Infrared Light‐Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image‐Guided Synergistic Phototherapy},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {19},
doi = {10.1002/adhm.202400201}
}
EUVIMED